Impaired adenosine-mediated angiogenesis in preeclampsia: potential implications for fetal programming

Area of Science:

• Obstetrics and Gynecology
• Cardiovascular Research
• Developmental Biology

Background:

• Preeclampsia is a pregnancy syndrome marked by hypertension and proteinuria after 20 weeks gestation.
• It involves impaired utero-placental blood flow, placental ischemia, and feto-placental endothelial dysfunction.
• Endothelial dysfunction in offspring of preeclamptic mothers is linked to later cardiovascular disease, including hypertension.

Purpose of the Study:

• To investigate the hypothesis that reduced adenosine-mediated angiogenesis in preeclamptic pregnancies is associated with hypertension development in offspring.
• To explore the role of the adenosine receptor A2A/nitric oxide/vascular endothelial growth factor axis in this process.

Main Methods:

• Review of existing evidence on endothelial function and cardiovascular risk in offspring exposed to preeclampsia.
• Analysis of studies examining the adenosine receptor A2A/nitric oxide/vascular endothelial growth factor axis in human umbilical vein endothelial cells from preeclamptic pregnancies.

Main Results:

• A reduced adenosine receptor A2A/nitric oxide/vascular endothelial growth factor axis was observed in endothelial cells from preeclamptic pregnancies.
• This reduction correlated with the gestational age at preeclampsia onset.
• Diminished endothelial function, indicated by low angiogenic capacity, is known to cause hypertension in animal models.

Conclusions:

• Impaired adenosine-mediated angiogenesis during preeclampsia may represent a mechanism linking maternal disease to offspring hypertension.
• Further research is warranted to confirm this association and explore potential therapeutic targets.